UFP Technologies, Inc. Effective Income Tax Rate Reconciliation, Tax Contingency, Amount
UFP Technologies, Inc. (UFPT) reported Effective Income Tax Rate Reconciliation, Tax Contingency, Amount of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationTaxContingencies · last filed 2026-02-27
- UFP Technologies, Inc. effective income tax rate reconciliation, tax contingency, amount for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- UFP Technologies, Inc. effective income tax rate reconciliation, tax contingency, amount for fiscal 2024 was $157.00K, a 76.57% decline from fiscal 2023.
- UFP Technologies, Inc. effective income tax rate reconciliation, tax contingency, amount for fiscal 2023 was $670.00K.
| Period end | Effective Income Tax Rate Reconciliation, Tax Contingency, Amount 12 month |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-27 |
| 2024-12-31 | $157.00K 10-K · filed 2026-02-27 |
| 2023-12-31 | $670.00K 10-K · filed 2026-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |